Abstract:The calcium-activated chloride channel TMEM16A is involved in many physiological processes, and insufficient function of TMEM16A may lead to the occurrence of various diseases. Therefore, TMEM16A activators are supposed to be potentially useful for treatment of TMEM16A downregulation-inducing diseases. However, the TMEM16A activators are relatively rare, and the underlying activation mechanism of them is unclear. In the previous work, we have proved that ginsenoside Rb1 is a TMEM16A activator. In this work, we explored the activation mechanism of ginsenoside analogs on TMEM16A through analyzing the interactions between six ginsenoside analogs and TMEM16A. We identified GRg2 and GRf can directly activate TMEM16A by screening five novel ginsenosids analogs (GRb2, GRf, GRg2, GRh2, and NGR1). Isolated guinea pig ileum assay showed both GRg2 and GRf increased the amplitude and frequency of ileum contractions. We explored the molecular mechanisms of ginsenosides activating TMEM16A by combining molecular simulation with electrophysiological experiments. We proposed a TMEM16A activation process model based on the results, in which A697 on TM7 and L746 on TM8 bind to the isobutenyl of ginsenosides through hydrophobic interaction to fix the spatial location of ginsenosides. N650 on TM6 and E705 on TM7 bind to ginsenosides through electrostatic interaction, which causes the inner half of α-helix 6 to form physical contact with ginsenosides and leads to the pore opening. It should be emphasized that TMEM16A can be activated by ginsenosides only when both the above two conditions are satisfied. This is the first, to our knowledge, report of TMEM16A opening process activated by small-molecule activators. The mechanism of ginsenosides activating TMEM16A will provide important clues for TMEM16A gating mechanism and for new TMEM16A activators screening.

Entering the spotlight: Chitosan oligosaccharides as novel activators of CaCCs/TMEM16A

The Natural Compound Cinnamaldehyde is a Novel Activator of Calcium-Activated Chloride Channel

Activation of TMEM16A by natural product canthaxanthin promotes gastrointestinal contraction

Inhibitory activities of curzerenone, curdione, furanodienone, curcumol and germacrone on Ca2+-activated chloride channels

Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway

The Molecular Mechanism of Ginsenoside Analogs Activating TMEM16A

Identification of a druggable pocket of the calcium-activated chloride channel TMEM16A in its open state

The Ca<SUP>2+</SUP>-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

Activation mechanisms of dimeric mechanosensitive OSCA/TMEM63 channels

Molecular mechanism of CaCCinh-A01 inhibiting TMEM16A channel

A comprehensive search for calcium binding sites critical for TMEM16A calcium-activated chloride channel activity

TMEM16 proteins: Ca2+‑activated chloride channels and phospholipid scramblases as potential drug targets (Review)

[Expression of TMEM16A in the colon of intractable functional constipation patients and its clinical implications].

Effects of chitosan oligosaccharides (COS) and FMT from COS-dosed mice on intestinal barrier function and cell apoptosis

Effect of Chitooligosaccharides with a Specific Degree of Polymerization on Multiple Targets in T2DM Mice

Structural and theoretical basis for drug development targeting TMEM16A: Inhibition mechanism of tracheloside analogs

Protective Effects of Sulfated Chitooligosaccharides with Different Degrees of Substitution in MIN6 Cells.

Chitosan oligosaccharides with degree of polymerization 2-6 induces apoptosis in human colon carcinoma HCT116 cells.

Stimulation-Induced Peripheral-Nerve Hyperemia - Mediation by Fibers Innervating Vasa-Nervorum

Modulation of tryptophan metabolism via AHR-IL22 pathway mediates the alleviation of DSS-induced colitis by chitooligosaccharides with different degrees of polymerization

Chitooligosaccharides Attenuated Hepatic Encephalopathy in Mice through Stabilizing Gut-Liver-Brain Disturbance